Related Experiment Video

Updated: Jun 7, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Diabetic specific aspects in antithrombotic therapy in patients with coronary artery disease

S Farhan1, T Höchtl, J Wojta

  • 1Department of Medicine, Cardiology and Emergency Medicine, Wilhelminen Hospital, Vienna, Austria. serdar.farhan@wienkav.at

Minerva Medica
|October 30, 2010
PubMed

Insights

Diabetic patients require combined antithrombotic therapy. Prasugrel and enoxaparin show significant benefits in reducing adverse events in diabetic patients with acute coronary syndromes and ST-elevation myocardial infarction, respectively.

Area of Science:

  • Cardiology
  • Pharmacology
  • Diabetology

Background:

  • Diabetic patients face higher risks of atherothrombotic events.
  • Optimal antithrombotic therapy is crucial for managing cardiovascular risks in diabetes mellitus (DM).
  • Existing research indicates varying efficacy of antithrombotic agents in diabetic populations.

Purpose of the Study:

  • To review the efficacy of antiplatelet and antithrombin therapies in diabetic patients with coronary artery disease (CAD).
  • To compare the effectiveness of specific agents like prasugrel and enoxaparin in diabetic individuals.
  • To identify optimal antithrombotic strategies for secondary prevention in diabetic CAD patients.

Main Methods:

  • Literature review of studies on antithrombotic therapies in diabetic patients with CAD.
  • Analysis of clinical trial data comparing different antiplatelet agents (e.g., prasugrel vs. clopidogrel) and antithrombins (e.g., enoxaparin vs. unfractionated heparin).
  • Evaluation of outcomes in diabetic versus non-diabetic patients undergoing procedures like percutaneous coronary intervention (PCI).

Main Results:

  • Prasugrel demonstrated superior efficacy over clopidogrel in reducing adverse events in diabetic patients with acute coronary syndromes (ACS), without increasing bleeding.
  • Glycoprotein IIb-IIIa inhibitors (GPI) showed greater benefits in diabetic subjects with ACS undergoing PCI compared to non-diabetics.
  • Enoxaparin proved superior to unfractionated heparin (UFH) in reducing adverse events in diabetic patients with ST-elevation myocardial infarction (STEMI) receiving thrombolytic therapy.

Conclusions:

  • Specific antiplatelet agents like prasugrel are highly effective for diabetic patients with ACS.
  • Enoxaparin is a preferred antithrombin for diabetic patients with STEMI undergoing thrombolysis.
  • Further research is needed on novel antithrombins (e.g., factor Xa inhibitors) in diabetic CAD patients.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...